Lpcat3tm1.1Igl
Targeted Allele Detail
|
Symbol: |
Lpcat3tm1.1Igl |
Name: |
lysophosphatidylcholine acyltransferase 3; targeted mutation 1, inGenious Targeting Laboratory |
MGI ID: |
MGI:6158452 |
Synonyms: |
Lpcat3-Flox |
Gene: |
Lpcat3 Location: Chr6:124639887-124681142 bp, + strand Genetic Position: Chr6, 59.17 cM
|
Alliance: |
Lpcat3tm1.1Igl page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:232731
|
Parent Cell Line: |
iTL IC1 (ES Cell)
|
Strain of Origin: |
C57BL/6NTac
|
|
Allele Type: |
|
Targeted (Conditional ready) |
Mutation: |
|
Insertion
|
|
|
Mutation details: A loxP site and an frt-flanked neomycin selection cassette was inserted between exons 2 and 3, and a second loxP site was inserted between exons 6 and 7. The neomycin selection cassette was removed via Flp-mediated recombination.
(J:232731)
|
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Lpcat3 Mutation: |
25 strains or lines available
|
|
Original: |
J:232731 Kabir I, et al., Small Intestine but Not Liver Lysophosphatidylcholine Acyltransferase 3 (Lpcat3) Deficiency Has a Dominant Effect on Plasma Lipid Metabolism. J Biol Chem. 2016 Apr 1;291(14):7651-60 |
All: |
3 reference(s) |
|